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Abstract
Introduction. The available immunohistochemical techniques have documented restricted distribution of vita-
mins in the mammalian brain. The aim of the study was to develop a highly specific antiserum directed against 
pantothenic acid to explore the presence of this vitamin in the mammalian brain.
Material and methods. According to ELISA tests, the anti-pantothenic acid antiserum used showed a good affinity 
(10–8 M) and specificity. The antiserum was raised in rabbits. Using an indirect immunoperoxidase technique, 
the mapping of pantothenic acid-immunoreactive structures was carried out in the rat brain.
Results. Pantothenic acid-immunoreactive perikarya were exclusively found in the intermediate part of the lateral 
septal nucleus. These cells were generally small, round, fusiform or pyramidal and showed 2–3 long (50–100 µm) 
immunoreactive dendrites. Any immunoreactive axons containing pantothenic acid were detected.
Conclusions. The very restricted anatomical distribution of the pantothenic acid suggests that this vitamin could 
be involved in some specific neurophysiological mechanisms. (Folia Histochemica et Cytobiologica 2016, Vol. 54, 
No. 4, 186–192)
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Introduction
Vitamins acting as coenzymes or cofactors play impor-
tant metabolic roles in many well-known biochemical 
pathways. Many studies, using chromatography, vita-
min-binding protein assays, enzymatic immunoassays 
and radioimmunoassays, have reported the presence 
of vitamins in body fluid and in several organs. How-
ever, using immunohistochemical (IHC) techniques, 
the anatomical distribution of these substances in the 
mammalian brain is less known. Since 2004 and using 
highly specific antibodies, the distribution of axons 
and/or perikarya containing several vitamins has been 
reported in the mammalian brain [1–7]. Thick and 
smooth immunoreactive axons containing thiamine 
(vitamin B1), riboflavin (vitamin B2), pyridoxal (vita-
min B6) or folic acid (vitamin B9) have been observed 
in the mesencephalon, thalamus, anterior commissure 
and/or cerebral cortex of the monkey (Macaca fasci­
cularis) [1–5], whereas cell bodies containing pyridoxal 
or vitamin C have been respectively visualized in the 
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hypothalamus and in the somatosensorial cortex (pre-
central gyrus) of the same species [4, 5]. Moreover, the 
distribution of immunoreactive structures containing 
vitamin C has been recently reported in the brainstem 
of children [8] and direct visualization of retinoic 
acid, in perikarya located in the rat hypothalamus, 
was also reported [6]. Most of vitamins studied using 
IHC techniques belong to the B series (B1, B2, B6 
and B9) [1–5]. The studies reported above have shown 
that the distribution of vitamins in the mammalian 
brain is restricted or very restricted and this suggests 
that vitamins may be involved in some very specific 
unknown mechanisms different from their known 
metabolic roles reported to date [1–6]. In order to 
increase our knowledge on the neuroanatomical 
distribution of B vitamin series, we have studied for 
the first time by the IHC technique the distribution 
of immunoreactive structures containing pantothenic 
acid (vitamin B5) in the mammalian brain. To carry 
out this research, a highly specific antiserum directed 
against D-pantothenic acid (PA) was developed.
Material and methods
Development of a new and highly specific antiserum directed 
against D-pantothenic acid. D-Pantothenic acid of 99.3% 
chemical purity was purchased from ICN Biomedicals 
(Aurora, OH, USA).
PA was dissolved in methanol (solution 1) and bovine 
serum albumin (BSA) in water (solution 2), both solutions 
contained triethylamine. A third solution was prepared con-
taining dimethylformamide and ethylchloroformiate (ECF). 
Then, solution 3 was poured into solution 1 (activation pro-
cess) and, after 10 min, the resulting solution was transferred 
drip by drip into solution 2. The final solution, containing 
the synthesized PA-BSA, was purified by dialysis in dialyze 
membranes with cut-off limits between 12 and 16 KDa. 
The purification was performed in one liter bucket at 4°C 
during 36 h, changing the bath every 2–3 h.
Animals. The animal studies were carried out according to 
the Spanish, French and European law and they were also 
approved by the research ethical committee of the University 
of Salamanca (Spain). Male rabbits (New Zealand white, 
body mass 2 kg, age 8 months) were immunized with one 
injection every two or three weeks over two months. Each 
subcutaneous administration (1 mL) was a mixture of PA- 
-BSA (250 µg) and of complete or incomplete Freund adju-
vant [9]. Two weeks after the second immunization, serum 
samples were obtained. Antisera were preabsorbed with 
lyophilized BSA-ECF, centrifuged and the floating phase 
was purified as described previously [9]. Antisera were tested 
before and after the purification process [9].
 
Immunohistochemistry. Five male adult Wistar rats (300–
–350 g) were used. Rats were perfused via the ascending 
aorta with physiological saline and paraformaldehyde (4%) 
[1–4, 6]. Brains were dissected out, post-fixed in the same 
fixative for 12–14 h and cryoprotected. Using a freezing 
microtome, 40–50 mm-thick sections were obtained, kept 
in phosphate-buffered saline (PBS) and processed for 
immunostaining as previously reported [1–4, 6]. In brief, 
free-floating sections were treated with H2O2 and methanol, 
pre-incubated in PBS containing 0.3% Triton X-100 and 
1% normal horse serum (mix solution) and then incubated 
overnight in the mix solution containing the PA antiserum 
(diluted 1:1,000) (denoted at Gemacbio, Saint Jean d’Illac, 
France, as AP090). Sections were washed in PBS and incu-
bated with biotinylated anti-rabbit immunogammaglobulin 
(BA-1,000, Vector, Burlington, CA, USA), diluted 1:200 
in the mix solution. Then, sections were incubated with 
a 1:100-diluted avidin-biotin-peroxidase complex (Vectastain 
PK-6,100, Vector) and washed in PBS and Tris-HCl buffer. 
Finally, tissue-bound peroxidase was developed with H2O2, 
using 3,3’-diaminobenzidine as chromogen.
For mapping and nomenclature, the stereotaxic atlas 
of Paxinos and Watson [10] was used. An Olympus DP50 
digital camera attached to a Unilux-12 microscope (Kyowa, 
Tokyo, Japan) was used to obtain photomicrographs. Using 
an Adobe Photoshop CS software (Adobe Systems Inc., San 
José, CA, USA), only the contrast and brightness of the 
images were adjusted.
Results
Specificity of the anti-pantothenic acid antiserum 
As previously described, antibodies were assessed 
and characterized by ELISA tests [9]. After titra-
tion and for competition experiments, the optimal 
dilution of the anti-PA antiserum was observed at 
1:60,000–1:70,000 (at 492 nm, the optical density 
was 1) [9]. This procedure was carried out for each 
structure considered as competitor; the choice of 
the competitor was made based on the similarity of 
its chemical structure to that of the target molecule 
(see Table 1).
The estimated antibody avidity (IC50) was fairly high 
(10–8 M for anti-PA-BSA antibodies, i.e. anti-PA-anti-
bodies) (Table 1). The specificity of these antibodies was 
very high, since the antiserum discriminated ana logous 
structures very well: pyridoxine, choline, retinoic acid, 
alpha-tocopherol, vitamin C and D-biotin (Table 1, 
Figure 1). No cross-reactivity was observed with any 
of the molecules tested. Moreover, the part of the 
antigen corresponding to the protein carrier was not 
detected when ELISA tests or the IHC technique were 
carried out, since in both cases no cross-linking was 
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observed. Thus, it may be concluded that the antiserum 
is specifically directed against PA due to the absence 
of cross-reactivity. 
Specificity of the immunoreactivity
The anti-PA antiserum was absorbed with the protein 
carrier (BSA) and the lyophilized coupling agent 
(ECF) (both used to synthesize the antigen). In order 
to avoid spurious signals, the absorption with ECF-
-BSA was performed before the IHC technique was 
carried out. Moreover, the immunoreactivity observed 
in the intermediate part of the lateral septal nucleus 
disappeared when the anti-PA antiserum was pre-ab-
sorbed with an excess of PA (Figure 2B) and when 
the first and/or the second antibodies were omitted.
Neuroanatomical observations
We observed a very restricted distribution of PA-im-
munoreactive structures. Cell bodies containing this 
vitamin were exclusively found in the intermediate 
part of the lateral septal nucleus (Figures 2, 3). No 
immunoreactive structures were visualized in the ven-
tral and dorsal parts of the same nucleus. Moreover, 
no PA-immunoreactive axons were observed in the 
rat brain. In the intermediate part of the lateral septal 
nucleus, we found a high density of immunoreactive 
perikarya (more than 20 cell bodies/nucleus/section) 
throughout the whole rostro-caudal extension of the 
intermediate part (Figures 2, 3). In all animals studied, 
we observed the same density and distribution of im-
munoreactive cell bodies. In general, these cell bodies 
were small (with a diameter below 15 µm), round, 
fusiform or pyramidal and showed two-three long 
(50–100 µm) immunoreactive dendrites (Figures 2, 3).
Discussion
Specificity of the developed anti-pantothenic acid 
antiserum
Due to the development by us at Gemacbio S.A. (Saint 
Jean d’Illac, France) of a new and highly specific an-
tiserum directed against PA, it has been possible to 
map the immunoreactive structures containing PA in 
the rat brain. This vitamin is a small molecule (a com-
pound with a molecular weight of 238.27 Da). Small 
molecules are not immunogenic and, for this reason, 
they are usually linked through a coupling agent (e.g., 
aldehydes, carbodiimides, picric acid) to a carrier 
protein [9]. The immune response is triggered by 
molecules weighing 1 to 2 kDa, which is the minimum 
size for stimulating antibody production. Animals 
receiving the immunogen (PA-coupling agent-carrier 
protein) will generate different types of polyclonal an-
tibodies, some of them will recognize PA, while other 
populations will recognize the carrier protein or the 
coupling agent (cross-linking). Antibodies directed 
against the carrier protein or the coupling agent could 
give a spurious signal that must be blocked, reduced 
Table 1. Affinity and specificity of antibodies directed 
against D-pantothenic acid
Compound Cross-reactivity at  
half-displacement (IC50)
D-Pantothenic acid-BSA 1
Pyridoxine-BSA > 1/1,000
Choline-BSA > 1/50,000
Retinoic acid-BSA > 1/50,000
a-tocopherol-BSA > 1/50,000
Vitamin C-BSA > 1/50,000
Biotin-BSA > 1/50,000
Using competition ELISA assays, cross-reactivity was calculated from 
the displacement curves at half-displacement: the best recognized 
was D-pantothenic acid-BSA, whose concentration was divided by the 
concentration of each of the other compounds. Abbreviations:  
BSA — bovine serum albumin.
Figure 1. Antibody affinity and specificity resulting from 
competition ELISA tests of pantothenic acid. Curve 1:  
competition with D-pantothenic acid-BSA. Curve 2: 
competition with pyridoxine-BSA. Curve 3: competition 
with vitamin C-BSA; this curve is also representative of the 
competition with choline-BSA, retinoic acid-BSA, a-toco-
pherol-BSA or biotin-BSA. For a better visualization of 
Figure 1, the curves of the latter four compounds have not 
been included. Abbreviations: B — optical density with 
competitor; Bo — optical density without competitor;  
BSA — bovine serum albumin; Log C — logarithm of 
concentration.
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or suppressed by later purification and checked after 
application of the respective controls.
According to the controls carried out in this study, it 
seems that the first antiserum (anti-PA) used here is very 
specific. Thus, the anti-PA antiserum was pre-absorbed 
with the carrier protein and the coupling agent in order 
to discard spurious signal due to antibodies directed 
against these parts of the antigen (cross-linking signal). 
Moreover, the pre-absorption of the first antiserum with 
D-PA-BSA and the omission of the first and/or second 
antisera showed the specificity of the immunoreactivity 
observed. ELISA tests revealed that D-PA was much 
better recognized than other competitors. Thus, the 
data demonstrate that the antibody directed against 
Figure 2. The distribution of pantothenic acid (PA) in lateral septal nucleus of rat brain. A. Frontal section (Bregma  
0.2 mm) of the rat telencephalon. PA-immunoreactive cell bodies (asterisks) are present in the intermediate (LSI) part of the 
lateral septal nucleus; B. After the pre-absorption of the first antibody, note the absence of immunoreactivity in the  
intermediate (LSI) part of the lateral septal nucleus. Compare this figure with Figure 2C; C. Cell bodies containing PA are 
located in the intermediate (LSI) part of the lateral septal nucleus; D. Higher-power magnification of the region delimited 
by the rectangle (middle) shown in Figure 2C; E, F. Higher-power magnification of the regions delimited by the lower and 
upper rectangles, respectively, shown in Figure 2C. Arrows indicate dendrites. Abbreviations: aca — anterior commissure, 
anterior part; BST — bed nucleus of the stria terminalis; cc — corpus callosum; CPu — caudate-putamen; D — dorsal; 
IG — induseum griseum; L — lateral; LSD — lateral septal nucleus, dorsal part; LSI — lateral septal nucleus, interme-
diate part; LSV — lateral septal nucleus, ventral part; LV — lateral ventricle; MS — medial septal nucleus; SHi — septo-
hippocampal nucleus; V — ventral; VDBD — nucleus of the vertical limb of the diagonal band, dorsal part.
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D-PA is highly specific. To sum up, we have applied two 
different techniques (IHC, ELISA) and both confirmed 
the specificity of the immunostaining visualized in the 
rat lateral septal nucleus.
Figure 3. Immunoreactive neurons containing pantothenic acid (PA) in the rat lateral septal nucleus. A. Cell bodies con-
taining PA; B. Higher-power magnification of the region delimited in the rectangle shown in Figure 3A; C. A PA-immu-
noreactive cell body; D. Higher-power magnification of the region delimited in the rectangle shown in Figure 3B;  
E–H. Cell bodies containing PA. Arrows indicate dendrites. Abbreviations: L — lateral; LV — lateral ventricle; V — ventral.
The presence of pantothenic acid  
in the lateral septal nucleus
After applying the Golgi staining method, the morpho-
logical characteristics (e.g. long dendrites, fusiform or 
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pyramidal cell bodies) of the neurons located in the rat 
lateral septum have been previously reported [11]. Our 
results are in agreement with this previous work [11]. 
Thus, comparing the morphological characteristics 
of the rat septal neurons (shape of the cell body, 
dendrites) with those reported here for the PA-im-
munoreactive cell bodies located in the intermediate 
part of the lateral septal nucleus, it seems that some 
neurons show the same morphological characteristics. 
Thus, for example, fusiform cell bodies with two long 
dendrites or pyramidal cells with three long dendrites 
can be observed when the Golgi method [11] or the 
IHC technique were carried out. It is known that the 
intermediate, dorsal and ventral parts of the lateral 
septal nucleus are interconnected [12]; however, no 
immunoreactive axons have been observed in the rat 
brain. The lack of immunoreactivity in axons could 
be due to the intraneuronal transport mechanisms of 
PA (stored exclusively in dendrites and perikarya). 
This has been previously published for some D-ami-
no acids (e.g. D-glutamate) and neuropeptides (e.g. 
somatostatin) [9, 13]. Moreover, it is also possible 
that the IHC technique applied here is not sensitive 
enough to detect PA because the level of PA stored 
in the axons is very low. 
Our previous works on the neuroanatomical dis-
tribution of vitamins in the mammalian brain [1–6] 
suggested the involvement of these substances in 
stress, somatosensorial, motor, food intake, visual, 
neuroendocrine and auditory mechanisms. To date, 
the role played by PA in the rat brain is unknown, 
but the presence of this vitamin in the intermediate 
part of the lateral septal nucleus suggests that PA 
could be involved in motivational and affective pro-
cesses [12]. It is known that the lateral septal nucleus 
send projections to the limbic system, which controls 
affective and motivational processes [12, 14], and 
receives afferents from the hypothalamus, amygdala, 
entorhinal cortex and hippocampus. Through these 
connections, the lateral septum integrates affective 
and cognitive information and sends this information 
to the brain regions involved in the control of the 
behavioral response [12].
Vitamins in the mammalian brain
Our results are in agreement with previous reports 
showing a restricted or a very restricted distribution 
of the immunoreactive structures containing vitamins 
in the mammalian brain [1–7]. Using IHC techniques, 
vitamins have been exclusively observed in axons (folic 
acid, riboflavin), cell bodies and dendrites (vitamin C, 
retinoic acid) or dendrites, axons and cell bodies 
(thiamine, pyridoxal) [1–7]. To date, the immunore-
active axons containing vitamins (folic acid, thiamine, 
riboflavin, pyridoxal) showed the same morphological 
characteristics: thick, smooth and unbranched [1–5]. 
These axons are very different from immunoreactive 
axons containing neuropeptides, since in general 
they show varicosities and are thin [15]. Here, we 
visualized cell bodies and dendrites containing PA, 
as it has been previously reported for vitamin C and 
retinoic acid [4, 6]. To date, immunoreactive struc-
tures containing vitamins have been found in the 
mesencephalon, thalamus, hypothalamus, cerebellum, 
anterior commissure and cerebral cortex [1–7]. Thus, 
we reported here for the first time the presence of 
immunoreactive structures containing a vitamin (PA) 
in the mammalian lateral septal nucleus. Moreover, 
our results confirm that in general vitamins show 
various anatomical distributions in the mammalian 
brain, although there are some brain nuclei (e.g., 
medial geniculate, pulvinar) in which two or three 
vitamins have been located (folic acid, thiamine and/ 
/or riboflavin) [1–3, 5]. Comparing the distribution 
of the vitamins studied in the mammalian brain, it 
is important to note that folic acid showed the most 
widespread distribution in the mammalian brain 
(immunoreactive axons were observed in 13 nuclei/ 
/regions located in the mesencephalon and thalamus), 
followed by thiamine (9 nuclei/regions located in the 
mesencephalon, thalamus and cerebral cortex), ribo-
flavin (7 nuclei/regions located in the mesencephalon 
and thalamus), pyridoxal (4 nuclei/regions located in 
the hypothalamus), retinoic acid (2 nuclei/regions 
located in the hypothalamus) and vitamin C (1 region 
located in the cerebral cortex) [1–7]. Thus, to date, 
the distributions of PA and vitamin C are the most 
restricted in the mammalian brain. The restricted 
distribution of PA suggests that the anti-PA antiserum 
used here is very specific against PA, because if the 
immunoreactivity observed was due to non-specific 
staining, this staining might have been distributed 
throughout the brain and not in a specific part of the 
lateral septal nucleus. Finally, in monkey, an IHC 
study has been carried out on the distribution of nicoti - 
namide (the amide of nicotinic acid or vitamin B3) 
and pyridoxine [4]. This study failed to demonstrate 
immunoreactive structures containing both vitamins.
The anatomical distribution of vitamins in the 
mammalian central nervous system by using highly 
specific antibodies directed against these substances 
is a new line of research that merits to be developed in 
the future. Vitamins show a specific neuroanatomical 
distribution in the mammalian brain and this suggests 
that these compounds may be involved in unsuspect-
ed physiological roles. Neuroanatomical studies are 
necessary in order to gain insight into the role played 
by vitamins in the brain regions in which vitamins are 
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found. The presence of PA-immunoreactive perikarya 
in the intermediate part of the lateral septal nucleus 
suggests that this vitamin could be involved in affective 
and motivational processes (e.g., depression, social 
behavior, mood, fear). Complementary physiological 
studies should be carried out to confirm the involve-
ment of PA in these processes.
In summary, using a highly specific anti-PA an-
tiserum, we have reported for the first time in the 
mammalian brain the presence and the morphological 
characteristics of the cell bodies containing PA.
Acknowledgements
This work has been supported by GEMAC S.A. Labor - 
atories (Saint Jean d’Illac, France), Institut pour le 
Développement de la Recherche en Pathologie Hu-
maine et Thérapeutique (IDRPHT, Talence, France) 
and by the European Union FP7 Collaborative Grant 
TargetBraIn (number 279017). We wish to thank 
Professor Miguel Merchán (INCYL, Salamanca, 
Spain) for technical facilities and Dr. Denis Bedat 
for supervising the English text.
References
1. Mangas A, Coveñas R, Geffard K et al. Folic acid in the 
monkey brain: an immunocytochemical study. Neurosci Lett. 
2004;362:258–261. doi: 10.1016/j.neulet.2004.03.034.
2. Mangas A, Coveñas R, Geffard K et al. Thiamine-like fibers 
in the monkey brain: an immunocytochemical study. Life Sci. 
2006;79:1121–1128. doi: 10.1016/j.lfs.2006.03.017.
3. Mangas A, Coveñas R, Geffard K et al. Riboflavin-like im-
munoreactive fibers in the monkey brain. Anat Embryol. 2006; 
211:267–272. doi: 10.1007/s00429-006-0080-6.
4. Mangas A, Coveñas R, Bodet D, Duleu S, Marcos P, Geffard M. 
Vitamins in the monkey brain: an immunocytochemical 
study. J Chem Neuroanat. 2009;38:1–8. doi: 10.1016/j.jchem-
neu.2009.05.007.
5. Coveñas R, Mangas A, Bodet D et al. Frontiers in vitamin 
research: new antibodies, new data. Sci World J. 2011;11:1226–
–1242. doi: 10.1100/tsw.2011.115.
6. Mangas A, Bodet D, Duleu S, Yajeya J, Geffard M, Co-
veñas R. Direct visualization of retinoic acid in the rat hy-
pothalamus: an immunohistochemical study. Neurosci Lett. 
2012;509:64–68. doi: 10.1016/j.neulet.2011.12.053.
7. Martínez-Rodríguez R, Arenas Díaz G, Carnicero MB. Thia-
mine-like molecules in the cerebellar cortex of the rat: light 
and electron microscopic immunocytochemical investigation. 
J Neurosci Res. 1989;23:447–453. doi: 10.1002/jnr.490230411.
8. Coveñas R, González-Fuentes J, Rivas-Infante E et al. Deve-
lopmental study of vitamin C distribution in children’s brain-
stems by immunohistochemistry. Ann Anat. 2015;201:65–78. 
doi: 10.1016/j.aanat.2015.06.001.
9. Mangas A, Coveñas R, Bodet D, Geffard M, Aguilar LA, 
Yajeya J. Immunocytochemical visualization of D-gluta-
mate in the rat brain. Neuroscience. 2007;144:654–664. doi: 
10.1016/j.neuroscience.2006.09.045.
10. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 
Sydney: Academic Press; 1982.
11. Alonso JR, Frotscher M. Organization of the septal region 
in the rat brain: a Golgi/EM study of lateral septal neurons. 
J Comp Neurol. 1989;286:472–487. doi: 10.1002/cne.902860406.
12. Sheehan TP, Chambers RA, Russell DS. Regulation of affect 
by the lateral septum: implications for neuropsychiatry. Brain 
Res Rev. 2004;46:71–117. doi: 10.1016/j.brainresrev.2004. 
04.009.
13. de León M, Coveñas R, Narváez JA, Tramu G, Aguirre JA, 
González-Barón S. Somatostatin-28 (1-12)-like immunoreac-
tivity in the cat diencephalon. Neuropeptides. 1991;19:107–117. 
doi: 10.1016/0143-4179(91)90140-E.
14. Swanson LW, Cowan WM. The connections of the septal 
region in the rat. J Comp Neurol. 1979;186:621–656. doi: 
10.1002/cne.901860408.
15. Pesini P, Pego-Reigosa R, Tramu G, Coveñas R. Distri-
bution of alpha-neo-endorphin immunoreactivity in the 
diencephalon and brainstem of the dog. J Chem Neuroanat. 
2001;22:251–262. PMID: 11719022. 
Submitted: 6 July, 2016 
Accepted after reviews: 24 November, 2016 
Available as AoP: 2 December, 2016
